BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34305900)

  • 1. Protective Role of Kynurenine 3-Monooxygenase in Allograft Rejection and Tubular Injury in Kidney Transplantation.
    Lassiter R; Merchen TD; Fang X; Wang Y
    Front Immunol; 2021; 12():671025. PubMed ID: 34305900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of indoleamine 2,3 dioxygenase and its role in a porcine model of acute kidney allograft rejection.
    Wang Y; Merchen TD; Fang X; Lassiter R; Ho CS; Jajosky R; Kleven D; Thompson T; Mohamed E; Yu M; Waller JL; Nahman NS
    J Investig Med; 2018 Dec; 66(8):1109-1117. PubMed ID: 30006478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenine 3-monooxygenase is a critical regulator of renal ischemia-reperfusion injury.
    Zheng X; Zhang A; Binnie M; McGuire K; Webster SP; Hughes J; Howie SEM; Mole DJ
    Exp Mol Med; 2019 Feb; 51(2):1-14. PubMed ID: 30760699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-hydroxykynurenine suppresses CD4+ T-cell proliferation, induces T-regulatory-cell development, and prolongs corneal allograft survival.
    Zaher SS; Germain C; Fu H; Larkin DF; George AJ
    Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2640-8. PubMed ID: 21212175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indoleamine 2,3-dioxygenase and metabolites protect murine lung allografts and impair the calcium mobilization of T cells.
    Iken K; Liu K; Liu H; Bizargity P; Wang L; Hancock WW; Visner GA
    Am J Respir Cell Mol Biol; 2012 Oct; 47(4):405-16. PubMed ID: 22517796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kynurenine 3-monooxygenase limits de novo NAD
    Zhai Y; Chavez JA; D'Aquino KE; Meng R; Nawrocki AR; Pocai A; Wang L; Ma LJ
    Am J Physiol Cell Physiol; 2024 May; 326(5):C1423-C1436. PubMed ID: 38497113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of human kynurenine-3-monooxygenase protects against 3-hydroxykynurenine-mediated apoptosis through bidirectional nonlinear feedback.
    Wilson K; Auer M; Binnie M; Zheng X; Pham NT; Iredale JP; Webster SP; Mole DJ
    Cell Death Dis; 2016 Apr; 7(4):e2197. PubMed ID: 27077813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proapoptotic activity of indoleamine 2,3-dioxygenase expressed in renal tubular epithelial cells.
    Mohib K; Guan Q; Diao H; Du C; Jevnikar AM
    Am J Physiol Renal Physiol; 2007 Sep; 293(3):F801-12. PubMed ID: 17609291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation.
    Brandacher G; Cakar F; Winkler C; Schneeberger S; Obrist P; Bösmüller C; Werner-Felmayer G; Werner ER; Bonatti H; Margreiter R; Fuchs D
    Kidney Int; 2007 Jan; 71(1):60-7. PubMed ID: 17136028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel therapy to attenuate acute kidney injury and ischemic allograft damage after allogenic kidney transplantation in mice.
    Gueler F; Shushakova N; Mengel M; Hueper K; Chen R; Liu X; Park JK; Haller H; Wensvoort G; Rong S
    PLoS One; 2015; 10(1):e0115709. PubMed ID: 25617900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine protease inhibitor-6 inhibits granzyme B-mediated injury of renal tubular cells and promotes renal allograft survival.
    Lau A; Khan K; Pavlosky A; Yin Z; Huang X; Haig A; Liu W; Singh B; Zhang ZX; Jevnikar AM
    Transplantation; 2014 Aug; 98(4):402-10. PubMed ID: 24918613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indoleamine 2,3-dioxygenase expression promotes renal ischemia-reperfusion injury.
    Mohib K; Wang S; Guan Q; Mellor AL; Sun H; Du C; Jevnikar AM
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F226-34. PubMed ID: 18480171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma?
    Connor TJ; Starr N; O'Sullivan JB; Harkin A
    Neurosci Lett; 2008 Aug; 441(1):29-34. PubMed ID: 18584961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue metabolic profiling shows that saccharopine accumulates during renal ischemic-reperfusion injury, while kynurenine and itaconate accumulate in renal allograft rejection.
    Beier UH; Hartung EA; Concors S; Hernandez PT; Wang Z; Perry C; Baur JA; Denburg MR; Hancock WW; Gade TP; Levine MH
    Metabolomics; 2020 May; 16(5):65. PubMed ID: 32367163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival.
    Lau A; Wang S; Jiang J; Haig A; Pavlosky A; Linkermann A; Zhang ZX; Jevnikar AM
    Am J Transplant; 2013 Nov; 13(11):2805-18. PubMed ID: 24103001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation.
    Garrison AM; Parrott JM; Tuñon A; Delgado J; Redus L; O'Connor JC
    Psychoneuroendocrinology; 2018 Aug; 94():1-10. PubMed ID: 29734055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of kynurenine 3-monooxygenase reduces mortality of acute viral myocarditis in mice.
    Kubo H; Hoshi M; Mouri A; Tashita C; Yamamoto Y; Nabeshima T; Saito K
    Immunol Lett; 2017 Jan; 181():94-100. PubMed ID: 27889626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes.
    Batal I; Mohan S; De Serres SA; Vasilescu ER; Tsapepas D; Crew RJ; Patel SS; Serban G; McCune K; Husain SA; Chang JH; Herter JM; Bhagat G; Markowitz GS; D'Agati VD; Hardy MA; Ratner L; Chandraker A
    Kidney Int; 2018 May; 93(5):1227-1239. PubMed ID: 29544662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the Th1/Th2 paradigm in transplantation: interferon-gamma deficiency converts Th1-type proislet allograft rejection to a Th2-type xenograft-like response.
    Simeonovic CJ; Townsend MJ; Karupiah G; Wilson JD; Zarb JC; Mann DA; Young IG
    Cell Transplant; 1999; 8(4):365-73. PubMed ID: 10478716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement Alternative Pathway Deficiency in Recipients Protects Kidney Allograft From Ischemia/Reperfusion Injury and Alloreactive T Cell Response.
    Casiraghi F; Azzollini N; Todeschini M; Fiori S; Cavinato RA; Cassis P; Solini S; Pezzuto F; Mister M; Thurman JM; Benigni A; Remuzzi G; Noris M
    Am J Transplant; 2017 Sep; 17(9):2312-2325. PubMed ID: 28276660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.